Proven to be reliable in treating bleeds.

The reliability of Novoeight® has been proven in one of the largest clinical studies programs to date, with 225 previously treated patients receiving 88,000 infusions.

Proven to be reliable in treating bleeds.

The reliability of Novoeight® has been proven in one of the largest clinical studies programs to date, with 225 previously treated patients receiving 88,000 infusions.


Oscar lives with hemophilia A.

How does it work?

When it’s activated, Novoeight® works like the factor VIII your body naturally produces to help control your bleeds.

In an initial clinical trial of Novoeight®, 91% of all bleeds were controlled with 1 or 2 doses.

In an initial clinical trial of Novoeight®, 91% of all bleeds were controlled with 1 or 2 doses.

Bleed control you can rely on.

Novoeight® was shown to be effective across a range of ages.

Initial clinical trials

In all patients 0 to

65 years old

In initial clinical trials, patients who took Novoeight® had a median of 3.1 bleeds per year.a  


In children 0 to

11 years old

In an initial clinical trial, children who took Novoeight® had a median of 3.0 bleeds per year.a  

Initial clinical trials

In all patients 0 to

65 years old

In initial clinical trials, patients who took Novoeight® had a median of 3.1 bleeds per year.a  

In children 0 to

11 years old

In an initial clinical trial, children who took Novoeight® had a median of 3.0 bleeds per year.a  

Safety extension trial

Most people who took part in the initial clinical trials continued to receive Novoeight® to further study safety. These people had a median of 1.6 bleeds per year.a,b  

aBased on median annualized bleed rate (ABR).
bBased on information as of September 1, 2012.


In adolescents and adults

12 to 65 years old

of bleeds were controlled with 1 or 2 doses.


In children

0 to 11 years old

of bleeds were controlled with 1 or 2 doses.


Of all people who had

major or minor surgery

of bleeds were controlled.

Novoeight® offers

storage flexibility.

Thermometer

Higher temperature stability of Novoeight® means storage flexibility for you.


What if I’m new to

Novoeight®?

It’s easy to get started; we’ll show you step-by-step.


Educational resources

for you.

These materials can help you start and manage your treatment.

Selected Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight® when you have surgery.

Novoeight® is not used to treat von Willebrand Disease.

Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII.

Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®.

Common side effects of Novoeight® include swelling or itching at the location of injection, changes in liver tests, and fever.

Please click here for Prescribing Information.

Novoeight® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800- FDA-1088.